RecruitingPhase 2NCT04802707
Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
Studying Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kenneth Myers, MD
- Principal Investigator
- Kenneth Alexis MD Myers, MD PhD FRCPCRI-MUHC, Children Hospital of Montreal (MUHC), McGill University
- Intervention
- deoxycytidine and deoxythymidine(combination_product)
- Enrollment
- 200 enrolled
- Eligibility
- 60 years · All sexes
- Timeline
- 2021 – 2029
Study locations (1)
- Research InstituMcGill University Health Centre - Children Hospital of Montreal, Montreal, Quebec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04802707 on ClinicalTrials.gov